These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 15758720

  • 1. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR.
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [Abstract] [Full Text] [Related]

  • 2. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
    Moul JW, Connelly RR, Lubeck DP, Bauer JJ, Sun L, Flanders SC, Grossfeld GD, Carroll PR.
    J Urol; 2001 Oct; 166(4):1322-7. PubMed ID: 11547066
    [Abstract] [Full Text] [Related]

  • 3. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O, Eggener SE, Bianco FJ, Carver BS, Serio A, Scardino PT, Eastham JA.
    J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [Abstract] [Full Text] [Related]

  • 4. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O.
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
    Tamblyn DJ, Chopra S, Yu C, Kattan MW, Pinnock C, Kopsaftis T.
    BJU Int; 2011 Nov; 108 Suppl 2():51-6. PubMed ID: 22085129
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
    Rouprêt M, Hupertan V, Comperat E, Drouin SJ, Phé V, Xylinas E, Demanse D, Sibony M, Richard F, Cussenot O.
    BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
    [Abstract] [Full Text] [Related]

  • 10. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA.
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
    Kawamorita N, Saito S, Ishidoya S, Ito A, Saito H, Kato M, Arai Y.
    Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
    [Abstract] [Full Text] [Related]

  • 17. Pathological findings and prostate-specific antigen outcomes after laparoscopic radical prostatectomy for high-risk prostate cancer.
    Ploussard G, Salomon L, Allory Y, Terry S, Vordos D, Hoznek A, Abbou CC, Vacherot F, de la Taille A.
    BJU Int; 2010 Jul; 106(1):86-90. PubMed ID: 19930177
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.
    Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR.
    Urology; 2007 Jul; 70(1):106-10. PubMed ID: 17656218
    [Abstract] [Full Text] [Related]

  • 19. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor.
    Penson DF, Grossfeld GD, Li YP, Henning JM, Lubeck DP, Carroll PR.
    J Urol; 2002 Apr; 167(4):1653-7; discussion 1657-8. PubMed ID: 11912382
    [Abstract] [Full Text] [Related]

  • 20. External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score.
    Zhao KH, Hernandez DJ, Han M, Humphreys EB, Mangold LA, Partin AW.
    Urology; 2008 Aug; 72(2):396-400. PubMed ID: 18372031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.